Article
Rising threats of ceftolozane-tazobactam resistance in P. aeruginosa and A. baumannii: Species-, phenotype-, and geography-specific insights from a systematic review and meta-analysis.
Indian journal of medical microbiology - 1 Jan 2026
Wang Hongda, Qiang Weidong, Fan Guoqiang
Abstract excerpt
BACKGROUND: Ceftolozane-tazobactam (C/T) is increasingly used to treat multidrug-resistant Gram-negative infections, but rising resistance threatens its effectiveness. Understanding global patterns is essential for guiding therapy and stewardship. METHODS: We conducted a systematic review and meta-analysis of studies reporting C/T resistance in Pseudomonas aeruginosa and Acinetobacter baumannii. Pooled resistance...
Read the complete abstract on PubMedTopics
- Tazobactam
- Pseudomonas aeruginosa
- Third Generation Cephalosporins
- Humans
- Anti-Bacterial Agents
- Acinetobacter baumannii
